RNA....Prosensa Holding NV...Down 70% or around 17pts...Failed Phase III trials with GSK for
Duchenne MD (same field as SRPT is going after and is up 5 plus pts on the news). The whole Duchenne
MD market is fairly small to begin with so hard to understand why both of these stocks were/are selling at
these inflated levels to begin with. Must be the platform applications. Just a reminder that the new drug,
bio market, is always a mine field out there....